These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16322856)
41. [Tear film changes after phacoemulsification]. Liu Z; Luo L; Zhang Z; Cheng B; Zheng D; Chen W; Lin Z; Yang W; Liu Y; Zhang M; Xiao Q; Chen J Zhonghua Yan Ke Za Zhi; 2002 May; 38(5):274-7. PubMed ID: 12133372 [TBL] [Abstract][Full Text] [Related]
42. Ocular surface inflammation, and nerve growth factor level in tears in active thyroid-associated ophthalmopathy. Yoon JS; Choi SH; Lee JH; Lee SJ; Lee SY Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):271-6. PubMed ID: 19844736 [TBL] [Abstract][Full Text] [Related]
43. Precorneal tear film in pterygium eye. Kampitak K; Leelawongtawun W J Med Assoc Thai; 2014 May; 97(5):536-9. PubMed ID: 25065094 [TBL] [Abstract][Full Text] [Related]
44. Graves' orbitopathy results in profound changes in tear composition: a study of plasminogen activator inhibitor-1 and seven cytokines. Ujhelyi B; Gogolak P; Erdei A; Nagy V; Balazs E; Rajnavolgyi E; Berta A; Nagy EV Thyroid; 2012 Apr; 22(4):407-14. PubMed ID: 22385289 [TBL] [Abstract][Full Text] [Related]
45. Parameters predicting outcomes of strabismus surgery in the management of Graves' ophthalmopathy. Nassar MM; Dickinson AJ; Neoh C; Powell C; Buck D; Galal E; Clarke MP J AAPOS; 2009 Jun; 13(3):236-40. PubMed ID: 19395292 [TBL] [Abstract][Full Text] [Related]
46. The repeatability of clinical measurements of dry eye. Nichols KK; Mitchell GL; Zadnik K Cornea; 2004 Apr; 23(3):272-85. PubMed ID: 15084861 [TBL] [Abstract][Full Text] [Related]
47. Diagnostic criteria for Graves' ophthalmopathy. Bartley GB; Gorman CA Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696 [TBL] [Abstract][Full Text] [Related]
48. [Inactive Graves' ophthalmopathy and self-esteem]. Magalhães CH; Pereira MD; Manso PG; Veiga DF; Novo NF; Ferreira LM Arq Bras Oftalmol; 2008; 71(2):215-20. PubMed ID: 18516421 [TBL] [Abstract][Full Text] [Related]
49. Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves' ophthalmopathy. Imbrasienė D; Jankauskienė J; Stanislovaitienė D Medicina (Kaunas); 2010; 46(7):472-6. PubMed ID: 20966620 [TBL] [Abstract][Full Text] [Related]
50. Tear-derived exosomal biomarkers of Graves' ophthalmopathy. Shi TT; Zhao RX; Xin Z; Hou ZJ; Wang H; Xie RR; Li DM; Yang JK Front Immunol; 2022; 13():1088606. PubMed ID: 36561758 [TBL] [Abstract][Full Text] [Related]
51. Comparison of tear function tests and impression cytology with the ocular findings in acne rosacea. Yaylali V; Ozyurt C Eur J Ophthalmol; 2002; 12(1):11-7. PubMed ID: 11936437 [TBL] [Abstract][Full Text] [Related]
52. Temporal progression and spatial repeatability of tear breakup. Liu H; Begley CG; Chalmers R; Wilson G; Srinivas SP; Wilkinson JA Optom Vis Sci; 2006 Oct; 83(10):723-30. PubMed ID: 17041317 [TBL] [Abstract][Full Text] [Related]
53. Tear film instability induced by rigid contact lenses. Itoh R; Yokoi N; Kinoshita S Cornea; 1999 Jul; 18(4):440-3. PubMed ID: 10422857 [TBL] [Abstract][Full Text] [Related]
54. Tear breakup dynamics: a technique for quantifying tear film instability. Begley CG; Himebaugh N; Renner D; Liu H; Chalmers R; Simpson T; Varikooty J Optom Vis Sci; 2006 Jan; 83(1):15-21. PubMed ID: 16432468 [TBL] [Abstract][Full Text] [Related]
55. TSHR intronic polymorphisms (rs179247 and rs12885526) and their role in the susceptibility of the Brazilian population to Graves' disease and Graves' ophthalmopathy. Bufalo NE; Dos Santos RB; Marcello MA; Piai RP; Secolin R; Romaldini JH; Ward LS J Endocrinol Invest; 2015 May; 38(5):555-61. PubMed ID: 25543543 [TBL] [Abstract][Full Text] [Related]
56. Effect of superior blepharoplasty on tear film: objective evaluation with the Keratograph 5M - a pilot study. Soares A; Faria-Correia F; Franqueira N; Ribeiro S Arq Bras Oftalmol; 2018 Nov./Dec.; 81(6):471-474. PubMed ID: 30304089 [TBL] [Abstract][Full Text] [Related]
57. Typical graves' ophthalmopathy in primary hypothyroidism. Kiran Z; Rashid O; Islam N J Pak Med Assoc; 2017 Jul; 67(7):1104-1106. PubMed ID: 28770897 [TBL] [Abstract][Full Text] [Related]
58. The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course. Jankauskiene J; Jarusaitiene D J Ophthalmol; 2017; 2017():4853905. PubMed ID: 29225963 [TBL] [Abstract][Full Text] [Related]
59. Natural history of graves' orbitopathy after treatment. Menconi F; Leo M; Sabini E; Mautone T; Nardi M; Sainato A; Sellari-Franceschini S; Vitti P; Marcocci C; Marinò M Endocrine; 2017 Aug; 57(2):226-233. PubMed ID: 27709471 [TBL] [Abstract][Full Text] [Related]
60. The course of Graves' ophthalmopathy is not influenced by near total thyroidectomy: a case-control study. Marcocci C; Bruno-Bossio G; Manetti L; Tanda ML; Miccoli P; Iacconi P; Bartolomei MP; Nardi M; Pinchera A; Bartalena L Clin Endocrinol (Oxf); 1999 Oct; 51(4):503-8. PubMed ID: 10583319 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]